{"version":"1.0","type":"link","title":"Pharmacovigilance analysis of infliximab in inflammatory bowel disease: novel safety signals and sex-specific adverse event profiles from the FAERS database (2004-2024).","author_name":"Liu W 외","author_url":"https://prs-insight.online/author/Liu%20W","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/79901","thumbnail_width":1200,"thumbnail_height":630}